Connect with us

Hi, what are you looking for?

News

Two doses of Pfizer, AstraZeneca shots effective against Delta variant, study finds

Image via US Secretary of Defense/CC BY 2.0/Wikimedia Commons

LONDON — Two doses of Pfizer or AstraZeneca’s coronavirus disease 2019 (COVID-19) vaccine are nearly as effective against the highly transmissible Delta coronavirus variant as they are against the previously dominant Alpha variant, a study published on Wednesday showed.

Officials say vaccines are highly effective against the Delta variant, now the dominant variant worldwide, though the study reiterated that one shot of the vaccines is not enough for high protection.

The study, published in the New England Journal of Medicine, confirms headline findings given by Public Health England (PHE) in May about the efficacy of COVID-19 vaccines made by Pfizer-BioNTech and Oxford-AstraZeneca, based on real-world data.

Wednesday’s study found that two doses of Pfizer’s shot was 88% effective at preventing symptomatic disease from the Delta variant, compared to 93.7% against the Alpha variant, broadly the same as previously reported.

Two shots of AstraZeneca vaccine were 67% effective against the Delta variant, up from 60% originally reported, and 74.5% effective against the Alpha variant, compared to an original estimate of 66% effectiveness.

“Only modest differences in vaccine effectiveness were noted with the Delta variant as compared with the Alpha variant after the receipt of two vaccine doses,” Public Health England researchers wrote in the study.

Data from Israel has estimated lower effectiveness of Pfizer’s shot against symptomatic disease, although protection against severe disease remains high.

PHE had previously said that a first dose of either vaccine was around 33% effective against symptomatic disease from the Delta variant.

The full study published on Wednesday found that one dose of Pfizer’s shot was 36% effective, and one dose of AstraZeneca’s vaccine was around 30% effective.

“Our finding of reduced effectiveness after the first dose would support efforts to maximize vaccine uptake with two doses among vulnerable groups in the context of circulation of the Delta variant,” the authors of the study said. — Reuters

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Editor’s Pick

People living in rural areas are having to travel further to find somewhere to withdraw and deposit cash free of charge, says the...

Editor’s Pick

Ministers have ruled out extending the list of workers who are exempt from self-isolation rules and warned that the August 16 date for...

News

Philippine-based companies that offer online gambling services to offshore markets, such as China, fueled office market growth in the country last year. — REUTERS...

News

PHILIPPINE STAR/ MICHAEL VARCAS President Rodrigo R. Duterte on Friday approved the recommendation of his pandemic task force to enforce stricter quarantine rules in...

News

https://www.sws.org.ph/ Thirty-seven percent of Filipinos are optimistic that their lives will improve over the next 12 months, a non-commissioned survey shows. Of the 1,200...

News

Energy Secretary Alfonso G. Cusi — PHILSTAR Six electricity consumers on Friday filed a complaint with the Ombudsman against Department of Energy (DoE) Secretary...

You May Also Like

When people envision technology overtaking society, many think of The Terminator and bulletproof robots. Or Big Brother in George Orwell’s Nineteen Eighty-Four, a symbol...

Financial Advisors

Stock Markets9 hours ago (Jul 02, 2020 04:45AM ET) (C) Reuters. ROME (Reuters) – World food prices rose in June to post their first...

Economy

SAN FRANCISCO — The spread of the coronavirus has meant feast or famine for technology start-ups. While many are cutting staff and slashing costs...

Economy

In Wisconsin and Ohio, farmers are dumping thousands of gallons of fresh milk into lagoons and manure pits. An Idaho farmer has dug huge...

Disclaimer: Respect Investment.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 Respect Investment. All Rights Reserved.

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!